# First Mid Bancshares, Inc.: financial statements, quarterly

FMBH · Nasdaq · CIK 700565 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmbh.md) · [Financials](/companies/fmbh/financials.md) · [Filings](/companies/fmbh/filings.md) · [Insiders](/companies/fmbh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fmbh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [30.0](/filings/0000950170-23-060773.md) | [32.5 d](/filings/0000950170-24-026921.md) | [32.2](/filings/0000950170-24-054010.md) | [31.9](/filings/0000950170-24-092347.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.4](/filings/0000950170-24-123741.md) | [3.6 d](/filings/0001193125-26-080847.md) | [6.4](/filings/0000950170-25-067613.md) | [7.0](/filings/0000950170-25-105507.md) | [5.9](/filings/0001193125-25-272249.md) | [6.2 d](/filings/0001193125-26-080847.md) | [6.0](/filings/0001193125-26-213797.md) | [6.7](/filings/0001193125-26-339679.md) | [6.3](/filings/0001193125-25-272249.md) | [6.3 d](/filings/0001193125-26-080847.md) | [7.6](/filings/0001193125-26-213797.md) | [8.5](/filings/0001193125-26-339679.md) |
| Net income | $m | [15.1](/filings/0000950170-24-123741.md) | [18.1 d](/filings/0001193125-26-080847.md) | [20.5](/filings/0000950170-25-067613.md) | [19.7](/filings/0000950170-25-105507.md) | [19.5](/filings/0001193125-25-272249.md) | [19.2 d](/filings/0001193125-26-080847.md) | [22.2](/filings/0001193125-26-213797.md) | [23.4](/filings/0001193125-26-339679.md) | [22.5](/filings/0001193125-25-272249.md) | [23.7 d](/filings/0001193125-26-080847.md) | [26.3](/filings/0001193125-26-213797.md) | [27.8](/filings/0001193125-26-339679.md) |
| Diluted EPS | $ per share | [0.68](/filings/0000950170-24-123741.md) | not reported | [0.86](/filings/0000950170-25-067613.md) | [0.82](/filings/0000950170-25-105507.md) | [0.81](/filings/0001193125-25-272249.md) | not reported | [0.93](/filings/0001193125-26-213797.md) | [0.98](/filings/0001193125-26-339679.md) | [0.94](/filings/0001193125-25-272249.md) | not reported | [1.06](/filings/0001193125-26-213797.md) | [1.04](/filings/0001193125-26-339679.md) |
| Basic EPS | $ per share | [0.68](/filings/0000950170-24-123741.md) | not reported | [0.86](/filings/0000950170-25-067613.md) | [0.83](/filings/0000950170-25-105507.md) | [0.81](/filings/0001193125-25-272249.md) | not reported | [0.93](/filings/0001193125-26-213797.md) | [0.98](/filings/0001193125-26-339679.md) | [0.94](/filings/0001193125-25-272249.md) | not reported | [1.06](/filings/0001193125-26-213797.md) | [1.05](/filings/0001193125-26-339679.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [7,855](/filings/0000950170-23-060773.md) | [7,587](/filings/0000950170-25-029793.md) | [7,678](/filings/0000950170-24-054010.md) | [7,581](/filings/0000950170-24-092347.md) | [7,562](/filings/0000950170-24-123741.md) | [7,520](/filings/0001193125-26-080847.md) | [7,573](/filings/0000950170-25-067613.md) | [7,680](/filings/0000950170-25-105507.md) | [7,830](/filings/0001193125-25-272249.md) | [7,967](/filings/0001193125-26-339679.md) | [9,289](/filings/0001193125-26-213797.md) | [9,210](/filings/0001193125-26-339679.md) |
| Total liabilities | $m | [7,117](/filings/0000950170-23-060773.md) | [6,794](/filings/0000950170-25-029793.md) | [6,880](/filings/0000950170-24-054010.md) | [6,767](/filings/0000950170-24-092347.md) | [6,704](/filings/0000950170-24-123741.md) | [6,673](/filings/0001193125-26-080847.md) | [6,702](/filings/0000950170-25-067613.md) | [6,786](/filings/0000950170-25-105507.md) | [6,898](/filings/0001193125-25-272249.md) | [7,008](/filings/0001193125-26-339679.md) | [8,212](/filings/0001193125-26-213797.md) | [8,108](/filings/0001193125-26-339679.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [354](/filings/0001193125-26-080847.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [738](/filings/0000950170-24-123741.md) | [793](/filings/0001193125-26-080847.md) | [798](/filings/0000950170-25-105507.md) | [814](/filings/0001193125-25-272249.md) | [858](/filings/0001193125-25-272249.md) | [846](/filings/0001193125-26-339679.md) | [871](/filings/0001193125-26-339679.md) | [894](/filings/0001193125-26-339679.md) | [932](/filings/0001193125-25-272249.md) | [959](/filings/0001193125-26-339679.md) | [1,077](/filings/0001193125-26-339679.md) | [1,102](/filings/0001193125-26-339679.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.4 d](/filings/0000950170-24-123741.md) | [28.8 d](/filings/0001193125-26-080847.md) | [29.0](/filings/0000950170-25-067613.md) | [24.0 d](/filings/0000950170-25-105507.md) | [33.1 d](/filings/0001193125-25-272249.md) | [38.3 d](/filings/0001193125-26-080847.md) | [47.9](/filings/0001193125-26-213797.md) | [7.7 d](/filings/0001193125-26-339679.md) | [33.0 d](/filings/0001193125-25-272249.md) | [42.2 d](/filings/0001193125-26-080847.md) | [25.1](/filings/0001193125-26-213797.md) | [26.3 d](/filings/0001193125-26-339679.md) |
| Capital expenditure | $m | [1.1 d](/filings/0000950170-24-123741.md) | [0.6 d](/filings/0001193125-26-080847.md) | [1.5](/filings/0000950170-25-067613.md) | [1.1 d](/filings/0000950170-25-105507.md) | [1.1 d](/filings/0001193125-25-272249.md) | [1.2 d](/filings/0001193125-26-080847.md) | [1.9](/filings/0001193125-26-213797.md) | [1.8 d](/filings/0001193125-26-339679.md) | [1.1 d](/filings/0001193125-25-272249.md) | [2.0 d](/filings/0001193125-26-080847.md) | [2.0](/filings/0001193125-26-213797.md) | [2.2 d](/filings/0001193125-26-339679.md) |
| Dividends paid | $m | [4.7 d](/filings/0000950170-24-123741.md) | [5.5 d](/filings/0001193125-26-080847.md) | [5.5](/filings/0000950170-25-067613.md) | [5.5 d](/filings/0000950170-25-105507.md) | [5.7 d](/filings/0001193125-25-272249.md) | [5.7 d](/filings/0001193125-26-080847.md) | [5.7](/filings/0001193125-26-213797.md) | [5.7 d](/filings/0001193125-26-339679.md) | [6.0 d](/filings/0001193125-25-272249.md) | [6.0 d](/filings/0001193125-26-080847.md) | [6.0](/filings/0001193125-26-213797.md) | [6.6 d](/filings/0001193125-26-339679.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-123741.md) | [0.5 d](/filings/0001193125-26-080847.md) | [0.0](/filings/0000950170-24-054010.md) | [0.0 d](/filings/0000950170-24-092347.md) | [0.0 d](/filings/0000950170-24-123741.md) | [0.7 d](/filings/0001193125-26-080847.md) | [0.0](/filings/0001193125-26-213797.md) | [0.0 d](/filings/0001193125-26-339679.md) | not reported | not reported | [0.5](/filings/0001193125-26-213797.md) | [0.9 d](/filings/0001193125-26-339679.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.5](/filings/0000950170-23-060773.md) | [20.6](/filings/0000950170-24-054010.md) | [20.6](/filings/0000950170-24-092347.md) | [22.3](/filings/0000950170-24-123741.md) | [24.0](/filings/0000950170-25-067613.md) | [24.0](/filings/0000950170-25-105507.md) | [24.0](/filings/0001193125-25-272249.md) | [24.0](/filings/0001193125-26-213797.md) | [24.0](/filings/0001193125-26-339679.md) | [24.0](/filings/0001193125-25-272249.md) | [24.9](/filings/0001193125-26-213797.md) | [26.6](/filings/0001193125-26-339679.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,601,912 at 2026-08-07, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339679.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.